20:31

Lifetime Management Considerations in Low Risk Patients
14:44

Understanding Early and Late Mortality in Low Risk Randomized Trials
17:23

High-Level Results of the Evolut™ Low Risk Randomized Clinical Trial
15:42

The Clinical Impact of Bioprosthetic Valve Performance After Surgery and TAVR
13:59

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team
16:16

Long-term Outcomes After TAVR
Subscribe to TAVR